INTERSTITIAL LUNG DISEASE: Progressive Restrictive Lung Disorders
Interstitial lung disease (ILD) refers to a broad group of disorders characterised by inflammation and fibrosis of the lung interstitium—the connective tissue framework that supports the alveoli and capillaries. Unlike obstructive lung diseases, which impair airflow, ILD primarily restricts lung expansion and disrupts gas exchange by thickening the alveolar–capillary membrane.
Although ILD encompasses many distinct conditions, including idiopathic pulmonary fibrosis, occupational lung diseases and connective tissue–associated lung disease, they share common pathophysiological features. Progressive stiffening of lung tissue increases the work of breathing, reduces lung volumes and leads to exertional hypoxaemia. Over time, ILD may progress to respiratory failure and pulmonary hypertension.
What You Need to Know
Interstitial lung disease (ILD) refers to a broad group of disorders characterised by inflammation and fibrosis of the pulmonary interstitium, the supportive tissue surrounding alveoli, capillaries, and small airways. The defining physiological abnormality is reduced lung compliance. As inflammatory processes and fibrotic tissue accumulate, the lungs become stiff and difficult to expand. This restricts inspiration and produces a restrictive ventilatory pattern, with reductions in total lung capacity, vital capacity, and inspiratory reserve volume. Patients must generate greater effort to achieve each breath, increasing the work of breathing even at rest.
Although airflow through the airways is often relatively preserved, gas exchange is significantly impaired. Thickening of the interstitial space increases the diffusion distance for oxygen as it moves from the alveoli into pulmonary capillaries. The core physiological disturbances that explain symptoms in ILD include:
Reduced lung compliance, making the lungs stiff and resistant to inflation
Restriction of lung volumes, limiting the depth of each breath
Impaired diffusion of oxygen, particularly under conditions of increased demand
These changes are especially evident during exertion. When activity increases, blood flows more rapidly through pulmonary capillaries, shortening the time available for oxygen diffusion. In healthy lungs this is not limiting, but in ILD the thickened interstitium prevents adequate oxygen transfer within the shortened transit time. As a result, patients develop early exertional dyspnoea and oxygen desaturation despite relatively normal airway calibre. Over time, persistent hypoxaemia, increased work of breathing, and progressive fibrosis contribute to declining exercise tolerance and worsening respiratory impairment.
Beyond the Basics
Inflammation and Fibrosis of the Interstitium
Many forms of interstitial lung disease begin with injury to the alveolar epithelium or the pulmonary capillary endothelium. This injury may arise from autoimmune activity, inhaled organic or inorganic dusts, medications, radiation exposure, or unknown triggers. The damaged tissue initiates an inflammatory response, with infiltration of immune cells into the interstitium. These cells release cytokines and growth factors that activate fibroblasts, the cells responsible for producing connective tissue.
Activated fibroblasts proliferate and deposit collagen and other extracellular matrix components, leading to progressive thickening of the interstitial space. In some ILDs, inflammation is prominent early and fibrosis may be partially reversible if the injurious stimulus is removed. In others, particularly idiopathic pulmonary fibrosis, fibrotic pathways dominate from the outset. In these cases, collagen deposition continues with minimal inflammation, resulting in irreversible architectural distortion of the lung and progressive loss of functional alveolar units.
Loss of Lung Compliance and Increased Work of Breathing
As fibrotic tissue replaces normal elastic lung parenchyma, lung compliance falls. The lungs become stiff and resistant to expansion, meaning greater transpulmonary pressure is required to achieve the same change in volume. This markedly increases the work of breathing. To compensate, patients adopt a rapid, shallow breathing pattern that reduces inspiratory effort and discomfort but limits tidal volume.
While this breathing strategy reduces the energy cost of each breath, it also decreases alveolar ventilation, particularly during exertion. As activity increases, the inability to increase tidal volume becomes a limiting factor, producing early breathlessness. Over time, the persistently elevated work of breathing places strain on respiratory muscles, which may fatigue, further worsening dyspnoea and reducing ventilatory reserve.
Gas Exchange Impairment and Diffusion Limitation
Thickening of the alveolar–capillary membrane is a central feature of ILD. Oxygen transfer becomes inefficient because oxygen must diffuse across an expanded interstitial barrier to reach the capillary blood. At rest, diffusion may be sufficient to maintain acceptable oxygenation, but during exercise, capillary blood flows more rapidly through the pulmonary circulation. This shortens the time available for oxygen diffusion, unmasking diffusion limitation.
Exertional hypoxaemia is therefore often one of the earliest physiological abnormalities in ILD. As disease progresses and fibrotic involvement expands, oxygen diffusion becomes inadequate even at rest. Persistent hypoxaemia may develop, eventually requiring supplemental oxygen to maintain tissue oxygen delivery and reduce secondary complications.
Pulmonary Hypertension and Right Heart Strain
Chronic hypoxaemia triggers hypoxic pulmonary vasoconstriction, a physiological response intended to redirect blood flow away from poorly ventilated lung regions. In ILD, this vasoconstriction becomes widespread and sustained. Fibrotic distortion and loss of pulmonary capillary beds further increase pulmonary vascular resistance.
Over time, the right ventricle must generate higher pressures to maintain pulmonary blood flow. This sustained pressure overload leads to right ventricular hypertrophy and, eventually, right ventricular dilation and failure. The development of pulmonary hypertension and right-sided heart failure marks advanced disease and is associated with a significant decline in functional capacity and prognosis.
Ventilation–Perfusion Mismatch
Interstitial lung disease produces heterogeneous involvement of lung tissue. Some regions become severely fibrotic and poorly ventilated, while others remain relatively preserved. This uneven distribution of ventilation leads to ventilation–perfusion mismatch, where blood flow continues through areas with limited oxygen uptake. The result is further impairment of arterial oxygenation.
Unlike obstructive lung diseases, carbon dioxide retention is uncommon until late stages. Increased respiratory drive and rapid breathing help maintain carbon dioxide elimination despite reduced lung volumes. However, as disease advances and respiratory muscle fatigue develops, ventilatory compensation may fail, contributing to respiratory insufficiency in end-stage ILD.
Clinical Connections
Interstitial lung disease most often presents with gradually progressive exertional dyspnoea, a persistent dry cough, and declining exercise tolerance. These symptoms reflect increasing lung stiffness and impaired oxygen transfer rather than airflow obstruction. On auscultation, fine end-inspiratory crackles are commonly heard, particularly at the lung bases, and are produced by the opening of stiff, fibrotic alveoli during inspiration. Digital clubbing may be present in chronic disease and indicates long-standing hypoxaemia and structural lung change.
Several clinical features are particularly helpful in raising suspicion of ILD and assessing progression:
Early breathlessness out of proportion to examination or spirometry, reflecting diffusion limitation
Dry, non-productive cough that persists despite preserved airway patency
Exertional oxygen desaturation, often preceding resting hypoxaemia
Pulmonary function testing typically demonstrates a restrictive pattern, with reduced total lung capacity and vital capacity, while the FEV₁/FVC ratio is preserved or increased because airflow is relatively unaffected. Diffusing capacity for carbon monoxide (DLCO) is often reduced early, reflecting thickening of the alveolar–capillary membrane and impaired gas transfer. High-resolution CT is central to diagnosis, as it characterises the distribution and pattern of interstitial involvement, distinguishes fibrotic from inflammatory processes, and helps guide prognosis and management.
Management is directed toward the underlying cause when identifiable, slowing fibrotic progression, correcting hypoxaemia, and maintaining functional capacity. Antifibrotic therapies may be used in selected conditions, while supplemental oxygen improves exercise tolerance and reduces secondary complications of chronic hypoxaemia. Ongoing assessment focuses on symptom progression, oxygen requirements, and functional decline, as ILD often follows an insidious but relentless course. Early recognition of worsening breathlessness, increasing oxygen needs, or reduced activity tolerance is essential to prompt reassessment and adjustment of care.
Concept Check
Why is interstitial lung disease classified as a restrictive lung disorder?
How does fibrosis of the interstitium impair gas exchange?
Why does exertional hypoxaemia often occur early in ILD?
How does ILD contribute to pulmonary hypertension?
Why is carbon dioxide retention usually a late finding in ILD?